KIF3B has been shown to be over-expressed in multiple human cancers, such as gastric cancer, oral squamous cell carcinoma, pancreatic cancer, prostate cancer, seminoma, hepatocellular carcinoma, and acute lymphoblastic leukemia (34–40). This evidence concerns the gene KIF3B and hepatocellular carcinoma.